Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.25-0.19 (-1.03%)
At close: 4:00PM EDT
18.25 0.00 (0.00%)
After hours: 04:33PM EDT
Advertisement

Meridian Bioscience, Inc.

3471 River Hills Drive
Cincinnati, OH 45244
United States
513 271 3700
http://www.meridianbioscience.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees750

Key Executives

NameTitlePayExercisedYear Born
Mr. John P. KennyPres, CEO & Director1.66MN/A1969
Mr. Bryan BaldasareExec. VP, Chief Accounting Officer, CFO & Sec.701.6k5.37kN/A
Dr. Lourdes G. Weltzien Ph.D.Exec. VP of Life Science Bus. Unit683.51kN/A1965
Mr. Tony Serafini-LamannaExec. VP of Diagnostics655kN/A1963
Mr. Jeff PinkstonDirector of Corp. Fin.N/AN/AN/A
Mr. Charles WoodVP of Corp. Strategy, Bus. Devel. & Investor RelationsN/AN/AN/A
Ms. Melissa J. McCareyVP of Global HRN/AN/AN/A
Ms. Susan D. RolihConsultantN/AN/A1949
Ms. Melissa A. LuekeConsultantN/AN/A1963
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare and PediaStat brands; and urea breath testing for H. pylori under the BreathID brand. This segment also offers gastrointestinal assays, including tests for C. difficile, H. pylori, and certain foodborne pathogens; respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry assays for testing elevated levels of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. The company has a strategic collaboration with DiaSorin Inc. to sell H. pylori tests. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

Corporate Governance

Meridian Bioscience, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 6. The pillar scores are Audit: 10; Board: 1; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement